Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Sun pharma MRs call it...

    Sun pharma MRs call it a strike on 26th September

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2016-09-12T12:37:55+05:30  |  Updated On 12 Sept 2016 12:37 PM IST
    Sun pharma MRs call it a strike on 26th September
    New Delhi : Around 500 Ex-workers of Ranbaxy, who are now working associted with the pharma giant Sun Pharma, have announced for a pan- India strike on september 26, against the non-payment of salaries and issues of Arbitrary Transfers by the company.

    Business Standard reports that these Medical representatives have not been paid their salary dues as well as travel expenses for the past three moths. Moreover, there are pending issues regarding the transfer of provident fund for those employees who became a part of Sun Pharma after the giant acquired Ranbaxy. Even after the one year integration process, , the provident fund account is yet to be transferred from the Ranbaxy Charitable Trust, making it difficult for employees to withdraw their PF after leaving the organisation, sources informed the
    daily
    .

    Another issue opposed by the MRs is the arbitrary transfers that have commenced after the integration process for which the MRs have also found support from the Indian Medical Association

    “How will a person who knows only Tamil be able to work in Assam without knowing the local language”, IMA asked Dilip Shanghvi, Director Sun Pharma referring to employees’ concerns. Three hundred MRs have already been reported to have resigned from the company because of these transfers

    In an e-mail response to this newspaper’s query on employees’ agitation, Sun Pharma said that the harmonisation process has been completed. The company did not wish to comment on the issue of compensation to the employees as the matter is sub judice. The matter will now be heard at the Bombay High Court as Sun Pharma challenged the order of the Labour Court of Maharashtra.

    medical representativesmedical representatives strikeMRRanbaxystrikeSun Pharma
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok